top of page
Group 1.png
d5cb957b9bfbc8eb083524b145e5e695c522e2ac.png
COMPANY

Leadership

SCROLL DOWN
“.png
PROTIER Biotech continues its rapid growth, driven by a leadership team composed of top experts in research, business strategy, and clinical development.
”.png
HyunTae Kim
Founder & CEO | Ph.D.

Hyuntae Kim, CEO of PROTIER Biotech, founded the company in May 2022 and has over 20 years of experience in the pharmaceutical and biotechnology industry, including research and development (R&D) and non-clinical development.

Background

  • Korea University (Ph.D.)

  • Head of Bio Research Institute at CrystalGenomics

  • Head of Synthetic Research Institute at AUTOTAC Bio

Performances

  • Project Lead for Structure-Based Drug Design (SBDD)

  • ​Achieved out-licensing of small-molecule compounds

  • Led the research and development of small-molecule drug candidates, including non-clinical stages

YuSeok Kim
CDO | D.V.M., Ph.D.

Vice President Yoo-Seok Kim joined PROTIER Biotech as Chief Development Officer (CDO) and has over 18 years of diverse experience in the pharmaceutical and biotechnology industries, including non-clinical and clinical trials.

Background

  • Seoul National University(Ph.D.)

  • Chong Kun Dang

  • Samsung Bioepis

Performances

  • Led non-clinical and clinical development of small-molecule and biologic therapeutics

  • ​R&D Project Lead

JiHyun Lee
CSO | Ph.D., MBA

Executive Director Lee Ji-hyun has joined PROTIER Biotech as Chief Strategy Officer (CSO) and possesses experience in various fields based on her 20 years of experience at global pharmaceutical and biotech companies.

Background

  • University of Illinois at Chicago (Ph.D.)

  • Postdoctoral Fellow at Stanford University, University of California at San Francisco

  • MBA, Korea University(MBA)

  • Drug Discovery Team at CrystalGenomics

  • Pfizer Medical Scientific Liaison

  • Sanofi Medical Scientific Liaison

Performances

  • R&D Project Lead

  • Responsible for Medical and Scientific Affairs

bottom of page